Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Reckitt Benckiser in talks to buy Mead Johnson for $16.7 billion

Published 02/02/2017, 08:36
Updated 02/02/2017, 08:36
© Reuters. Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic are seen in London

By Martinne Geller

(Reuters) - British consumer goods maker Reckitt Benckiser Group Plc (L:RB) is in advanced talks to buy baby formula maker Mead Johnson Nutrition Co (N:MJN) for $16.7 billion (13.2 billion pounds), in a deal that would take it in a new direction and boost its business in Asia.

Reckitt, which is best known for its cleaning and over-the-counter health products, said late on Wednesday it was in talks to offer $90 in cash for each Mead Johnson share, a 29.5 percent premium to the stock's closing price.

Shares of Mead Johnson, long rumoured to be a takeover target for Danone (PA:DANO) or Nestle (S:NESN), jumped 22 percent in after-market trading. At 0808 GMT, Reckitt shares in London were up 3.7 percent at 7,084 pence.

Mead Johnson, which makes Enfamil baby formula, has been seen as a bid target since being spun off from drugmaker Bristol-Myers Squibb in 2009, due in part to its big presence in Latin America and Asia, regions with fast-growing populations.

Reckitt, which makes Durex condoms, Nurofen tablets, Lysol cleaners and Scholl footcare products, was not seen as an obvious buyer given it is not in the baby food business and its overall food business is very small.

Still, Reckitt's focus on consumer health products, or health-related goods sold over the counter, makes Mead Johnson a good fit, analysts said.

"It's a branded consumer proposition with healthcare-y attributes," said RBC Capital Markets analysts, adding the absence of any product overlap meant antitrust scrutiny would be minimal.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Reckitt's proposed price represents a multiple of 17 times Mead Johnson's estimated 2017 earnings before interest, tax, depreciation and amortisation (EBITDA), said analysts at Wells Fargo (NYSE:WFC), falling short of the 20 times Nestle paid for Wyeth in 2012 and the 22 times Danone paid for Numico in 2007.

Still, the premium is in line with other recent consumer staples deals, and is appropriate given regulatory changes in China and price promotion, the analysts said.

Reckitt said it expected to finance the proposed deal through cash and debt.

"The parties are presently engaged in a period of due diligence and contract discussion," it said in a statement. Mead Johnson also confirmed the discussions in a statement.

Sources told Reuters in 2014 that Danone was interested in buying Mead Johnson but the French company has since agreed to buy WhiteWave (N:WWAV), known for its soy- and nut-based milks, reducing the chances of a counterbid.

Speculation regarding a bid by Nestle recently resurfaced after a media report citing unidentified sources, yet Nestle's existing baby formula business would likely throw up antitrust concerns.

The Wall Street Journal first reported on the talks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.